Market News

HKTDCen





Market News
Items Per Page
Title Source Publish Date
1.
Imports of Synthetic Cannabinoids Restricted
The Drug Enforcement Administration has issued an order that temporarily schedules the following six synthetic cannabinoids, along with their optical, positional and geometric isomers, salts and salts of isomers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.
Economists' Pick 28 April 2017
2.
European Parliament Approves Tougher Safety and Traceability Rules for Medical Devices
On 5 April 2017, the European Parliament formally approved two proposed Regulations imposing stricter rules on the safety of medical devices and in vitro diagnostic medical devices. The proposals, which replace three existing Directives regulating medical devices in the EU, bring a number of important changes to the current regulatory regime, including stricter pre-market controls and enhanced traceability requirements.
Economists' Pick 21 April 2017
3.
HKTDC Hong Kong International Medical Devices and Supplies Fair
The fair features the latest in medical devices and supplies, including medical and laboratory equipment and disposables, bringing together product developers and businesses looking to market these products.
Economists' Pick 18 April 2017
4.
LAOS: New Tax Incentives Unveiled for Designated Projects in Undeveloped Regions
Extended tax incentives are now on offer for FDI projects operating in the less-developed regions of the country. In particular, projects in the agriculture and healthcare sectors will qualify for profit tax exemptions for five years in areas with under-developed infrastructure and for three years in places where the infrastructure is more developed.
Economists' Pick 18 April 2017
5.
Imports of Synthetic Opioid Restricted
The Drug Enforcement Administration has issued a final order that temporarily schedules the synthetic opioid N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or para-fluoroisobutyryl fentanyl) and its isomers, esters, ethers, salts and salts of isomers, esters and ethers into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.
Economists' Pick 13 April 2017
6.
Getting a Slice of Indonesia’s Food and Pharma Sectors
With Indonesia's pharmaceutical and food and beverage (F&B) manufacturing industries growing rapidly, Jakarta's AllPack Indonesia trade event last October offered valuable insights into these increasingly competitive sectors.
Economists' Pick 12 April 2017
7.
Import Controls Adopted on Substance Used in Epilepsy Drugs
The Drug Enforcement Administration has adopted as final without change a May 2016 interim final rule placing brivaracetam, including its salts, into schedule V of the Controlled Substances Act.
Economists' Pick 31 March 2017
8.
New Import Controls on Ten Synthetic Cathinones
The Drug Enforcement Administration has issued a final rule that, effective 1 March, placed the following synthetic cathinones, including their optical, positional and geometric isomers, salts and salts of isomers whenever their existence is possible, into schedule I of the Controlled Substances Act.
Economists' Pick 17 March 2017
9.
Vast Indonesian Food and Pharma Sectors Lure Overseas Manufacturers
The sheer size and the rapid projected growth rate of Indonesia's pharmaceutical and food and beverage manufacturing sectors have proven to be irresistible lures to many of the world’s leading processing and industrial machinery suppliers.
Economists' Pick 3 March 2017
10.
Import Restrictions on Three Synthetic Cannabinoids Extended
The Drug Enforcement Administration has extended the temporary placement of three synthetic cannabinoids into Schedule I of the Controlled Substances Act until 27 January 2018 or until a permanent scheduling proceeding is completed, whichever occurs first.
Economists' Pick 17 Feb 2017
11.
INDONESIA: Mandatory Halal Certification Looms for Food, Pharmaceuticals and Cosmetics
Halal certification will be mandatory for all food, pharmaceutical and cosmetic products from October 2019. Promoted as a Halal Product Guarantee, the certification forms part of the bid to make Indonesian products more competitive in the international market, especially among the world’s estimated 1.9 billion global Muslim consumers.
Economists' Pick 25 Jan 2017
12.
FDA Bans Powdered Medical Gloves
The Food and Drug Administration has issued a final rule that, effective 18 January, will ban powdered surgeon’s gloves, powdered patient examination gloves, and absorbable powder for lubricating a surgeon’s glove after having determined that these goods present an unreasonable and substantial risk of illness or injury that cannot be corrected or eliminated by labelling or a change in labelling.
Economists' Pick 6 Jan 2017
13.
ACE Entry Filing Requirements for FDA-Regulated Goods Finalised
The Food and Drug Administration has issued a final rule that, effective 29 December, will require certain data elements material to admissibility reviews on imported FDA-regulated products to be submitted in the Automated Commercial Environment (or any other electronic data interchange system authorized by U.S. Customs and Border Protection) at the time of entry.
Economists' Pick 16 Dec 2016
14.
Imports of Synthetic Opioid Restricted
The Drug Enforcement Administration has issued a final order that temporarily schedules the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (also known as U-47700) and its isomers, esters, ethers, salts, and salts of isomers, esters and ethers into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.
Economists' Pick 2 Dec 2016
15.
Argentina Bans Imports of Pure gamma-Butyrolactone and Ethyl Chloride, Amends Trade Controls on Drug Precursors
Argentina has banned through Disposition 11276/2016 the importation, exportation and sale of pure gamma-butyrolactone (GBL) and ethyl chloride because these substances may be used as precursors in the manufacture of prohibited drugs.
Economists' Pick 4 Nov 2016
16.
FDA Warns Against Use of Homeopathic Teething Tablets and Gels
The Food and Drug Administration is warning U.S. consumers against the use of homeopathic teething tablets and gels because they may pose a health risk to infants and children.
Economists' Pick 4 Nov 2016
17.
Import Controls Imposed on Three Synthetic Phenethylamines
The DEA has issued a final rule that, effective 27 October, will permanently place the following substances, including their optical, positional, and geometric isomers, salts, and salts of isomers whenever their existence is possible, into schedule I of the Controlled Substances Act.
Economists' Pick 7 Oct 2016
18.
Moves to Fuse TCM with Western Medicine Gaining Traction Across Asia
With the active ingredients in Traditional Chinese Medicine now far better understood than ever before, a new range of hybrid TCM/Western treatments are wooing even the most cynical with their efficacy and lack of side-effects.
Economists' Pick 28 Sept 2016
19.
FDA Revises Regulations on Foreign and Domestic Drug Establishment Registration
The FDA has issued a final rule that reorganises, modifies and clarifies its regulations concerning how and when owners or operators of foreign and domestic establishments at which drugs are manufactured or processed must register their establishments with the FDA and list the drugs they manufacture or process.
Economists' Pick 23 Sept 2016
20.
Asia Poised to Step Up as World's Second Largest Medtech Market
Thanks to the ever-rising wealth and increased longevity of its citizens, Asia will soon be second only to the US as a medtech market, with diagnostically-enabled wearables and the digitisation of medicine set to make a huge impact.
Economists' Pick 23 Sept 2016
Items Per Page
Page  Of   8
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 Next